About Ovid Therapeutics Inc. Common Stock
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential in-class mechanism of action.
Market Cap
$0.03B
Employees
23
Listed Since
May 5, 2017
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.ovidrx.comPhone
212-776-4381
Headquarters
441 NINTH AVENUE, 14TH FLOOR
NEW YORK, NY 10001
CIK
0001636651